Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Arkray KDK Corp.

www.arkray.co.jp

Latest From Arkray KDK Corp.

Exclusive: Japan’s Mitsui Sells Its Entire Equity Stake In India’s Arch Pharma

Mitsui, the Japanese conglomerate, is believed to have sold its equity stake in Arch Pharma. The deal was concluded amicably but the conditions imposed by financial institutions to agree to a debt restructuring proposal may have been a factor for an untimely exit.

BioPharmaceutical India
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Arkray KDK Corp.
  • Senior Management
  • Shigeru Doi, Pres. & CEO
    Akie ONO, Head, R&D, Production
  • Contact Info
  • Arkray KDK Corp.
    Phone: (81) 75 662 8967
    57 Nishi Aketa-cho, Higashi-Kujo
    Minami-ku
    Kyoto, 601
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register